WebApr 6, 2024 · A high-level overview of Bio-Path Holdings, Inc. (BPTH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebGet the latest Bio Path Holdings Inc (BPTH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …
Should I buy Bio-Path Holdings (BPTH) - Zacks
WebMar 17, 2024 · The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ... WebPrice/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. Price/Book: A financial ratio used to compare a company's current market price … login as local user powershell
Bio-Path Holdings (BPTH) Price To Free Cash Flow - Zacks.com
WebThe current Bio-Path Holdings share price is $1.67. The Score for BPTH is 47, which is 6% below its historic median score of 50, and infers higher risk than normal. BPTH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels. WebApr 14, 2024 · The business’s 50-day moving average price is $17.36 and its two-hundred day moving average price is $18.60. Relay Therapeutics has a 1 year low of $12.65 and a 1 year high of $33.06. WebFor Bio-Path Holdings stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Bio-Path Holdings stock forecast of $0.81, a high forecast of $0.84, and a low forecast of $0.73. The average Bio-Path Holdings stock forecast 2026 represents a -56.03% decrease from the last price of $1.8474999666214. login as local user windows 10